All Stories

  1. Comparison of effectiveness and safety of imipenem/clavulanate-versusmeropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB

    Article • European Respiratory Journal, April 2016, European Respiratory Society (ERS)

    Dr Simon Tiberi

  2. Is there still room for therapeutic drug monitoring of linezolid in patients with tuberculosis?

    Article • European Respiratory Journal, April 2016, European Respiratory Society (ERS)

    Dr Simon Tiberi

  3. Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic Review

    Article • International Journal of Molecular Sciences, March 2016, MDPI AG

    Dr Simon Tiberi

  4. Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB

    Article • European Respiratory Journal, March 2016, European Respiratory Society (ERS)

    Dr Simon Tiberi

  5. The Need for Global Regulation of Antibiotics: The Case of a Generic Oral Penem

    Article • Clinical Infectious Diseases, March 2016, Oxford University Press (OUP)

    Dr Simon Tiberi

  6. Effectiveness and Safety of Imipenem-Clavulanate Added to an Optimized Background Regimen (OBR) Versus OBR Control Regimens in the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis

    Article • Clinical Infectious Diseases, February 2016, Oxford University Press (OUP)

    Dr Simon Tiberi

  7. Ertapenem in the treatment of multidrug-resistant tuberculosis: first clinical experience: TABLE 1

    Article • European Respiratory Journal, November 2015, European Respiratory Society (ERS)

    Dr Simon Tiberi

  8. Tuberculosis elimination, patients' lives and rational use of new drugs: revisited: TABLE 1

    Article • European Respiratory Journal, November 2015, European Respiratory Society (ERS)

    Dr Simon Tiberi

  9. Linezolid tolerability in multidrug-resistant tuberculosis: a retrospective study: TABLE 1

    Article • European Respiratory Journal, July 2015, European Respiratory Society (ERS)

    Dr Simon Tiberi

  10. Inverse psoriasis

    Article • Clinical Medicine, June 2015, Royal College of Physicians

    Dr Simon Tiberi

  11. Multidrug-Resistant Tuberculosis in Europe, 2010–2011

    Article • Emerging Infectious Diseases, March 2015, Centers for Disease Control and Prevention (CDC)

    Dr Valeriu Crudu, Dr Valeriu Crudu, Dr Simon Tiberi, Dr Emanuele Pontali, Dr Frank van Leth

  12. Bronchopleural fistula, tuberculous empyema and bilateral lung destruction treated in various stages by medical and surgical intervention

    Article • Indian Journal of Thoracic and Cardiovascular Surgery, July 2014, Springer Science + Business Media

    Dr Simon Tiberi

  13. Protecting ourselves from tuberculosis. Describing a historic poster printed in italy on 1937

    Article • Lung India, January 2014, Medknow

    Dr Simon Tiberi

  14. Differential diagnosis of a palmar and plantar rash

    Article • BMJ, September 2013, BMJ

    Dr Simon Tiberi

  15. Tuberculosis a re-emerging disease

    Article • Internal and Emergency Medicine, October 2012, Springer Science + Business Media

    Dr Simon Tiberi

  16. Efficacy and safety of meropenem–clavulanate added to linezolid-containing regimens in the treatment of MDR-/XDR-TB

    Article • European Respiratory Journal, September 2012, European Respiratory Society (ERS)

    Dr Simon Tiberi

  17. A strange case of waitress headache

    Article • The Lancet, November 2011, Elsevier

    Dr Simon Tiberi

  18. Viro-immunological dynamics in HIV-1-infected subjects receiving once-a-week emtricitabine to delay treatment change after failure: A pilot randomised trial

    Article • Journal of Clinical Virology, March 2010, Elsevier

    Dr Simon Tiberi

  19. HIV-1 replication capacity and genotype changes in patients undergoing treatment interruption or lamivudine monotherapy

    Article • Journal of Medical Virology, January 2007, Wiley

    Dr Simon Tiberi